Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.
The Epstein-Barr virus (EBV) major outer envelope glycoprotein complex, gp350/220, was known to be a ligand for CR2, a B-lymphocyte plasma membrane protein. By Scatchard analysis, soluble EBV gp350/220 binds with high affinity (KD, 1.2 x 10(-8) M) to approximately the same number of B-lymphocyte sur...
Sparad:
| I publikationen: | J Virol |
|---|---|
| Huvudupphov: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1988
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC253554/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2460635/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.62.12.4452-4464.1988 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
